About Kelly Chibale

Main areas of expertise

Small molecule drug discovery underpinned by the integration of chemistry, biology and pre-clinical pharmacology, including drug metabolism and pharmacokinetics (DMPK) as expressed in the processes of Absorption, Distribution, Metabolism & Excretion (ADME). Positions held

  • Neville Isdell Chair in African-centric Drug Discovery & Development
  • Tier 1 South Africa Research Chair in Drug Discovery under the South African Research Chairs Initiative of the Department of Science and Technology (DST) administered through the South African National Research Foundation (NRF), 2008-date
  • Founding Director, South African Medical Research Council Drug Discovery and Development (extramural) Research Unit at UCT, 2009-date
  • Founder and Director, UCT Drug Discovery and Development Centre (H3D), 2010-date
  • Full Professor (ad hominem promotion), Department of Chemistry, UCT, 2007-date
  • Full Member, Institute of Infectious Disease and Molecular Medicine (IDM), UCT, 2006-date